Jefferies raises Zentალis Pharmaceuticals to buy from hold, raises target price to $7 from $6
ZNTL•Jefferies raised its rating on Zentալis Pharmaceuticals to buy from hold and its target price to $7 from $6.
ZNTL•ZNTL•ZNTL•Jefferies raised its rating on Zentալis Pharmaceuticals to buy from hold and its target price to $7 from $6.
